MEM

MEM is a rare psychedelic amphetamine first synthesized by Alexander Shulgin and described in PiHKAL as entry #122. It is structurally related to mescaline and other DOx compounds. Human data is extremely limited, making effects unpredictable. Known for producing strong visual and cognitive effects with notable stimulation. Notable reports describe synergy with MDMA, with Myron Stolaroff noting the combination as particularly powerful for therapeutic work.

Classification

Chemical: Amphetamine
Chemical: Phenethylamine
Psychoactive: Psychedelic
Psychoactive: Stimulant
Tag: DOx-compound
Tag: Research-Chemical
Tag: Tentative

Effects

Stimulation
Vasoconstriction
Pupil Dilation
Increased Heart Rate
Mentalphysical Stimulation
Decreased Appetite
Euphoria
Analysis Enhancement
Conceptual Thinking
Time Distortion
Empathy Enhancement
Anxiety
Visual Enhancement
Color Enhancement
Pattern Recognition Enhancement
Drifting
Tactile Enhancement
Brightened Color

Routes of Administration

Oral

Dosage

Threshold: ~10 mg (tentative; some users report first alerts in the teens)
Light: 20-30 mg
Common: 30-50 mg
Strong: 50–70 mg
Heavy: 70+ mg

Duration

Onset: 0.5-1.5 h
Comeup: 1-2 h
Peak: 3-6 h
Offset: 6-10 h
After Effects: 10-24 h
Total Duration: 10-16 h

Harm Reduction

Check interactions before mixing substances, pay attention to dose spacing and hydration, and treat all dosage guidance as approximate rather than guaranteed safe.

Sources

Substance data is aggregated from the following public harm-reduction and reference sources.

Links

This static page is intended as a readable non-JS and prerender-friendly library export.

Get the full DrugsPRO experience

Open the interactive DrugsPRO app for search, saved items, interactions, and deeper harm reduction tools.

Get the PRO test kit. The simple, quick and reliable drug checking test kit. Visit https://protestkit.eu

MEM